MYLAN 5300 MYLAN 5300 (Nizatidine 300 mg)

Pill imprint MYLAN 5300 MYLAN 5300 has been identified as Nizatidine 300 mg.

Nizatidine is used in the treatment of gerd; indigestion; erosive esophagitis; duodenal ulcer; stomach ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 5300 MYLAN 5300

Nizatidine 300 mg MYLAN 5300 MYLAN 5300 Front
Nizatidine 300 mg MYLAN 5300 MYLAN 5300 Back
Nizatidine 300 mg MYLAN 5300 MYLAN 5300
Nizatidine 300 mg MYLAN 5300 MYLAN 5300
Nizatidine
Imprint:
MYLAN 5300
MYLAN 5300
Strength:
300 mg
Color:
Purple
Size:
17.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5300
Inactive Ingredients:
ammonia
lactose anhydrous
silicon dioxide
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
gelatin
isopropyl alcohol
magnesium stearate
butyl alcohol
corn starch
propylene glycol
shellac
dimethicone
sodium lauryl sulfate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)